STOCKHOLM, Sweden, September 12 /PRNewswire/ --

- New Data on the Mechanism of Action of the Second Generation 5-HT3 Antagonist palonosetron Presented Today at the 33rd ESMO Congress in Stockholm, Sweden

LONDON, September 12 /PRNewswire/ -- Unite, the UK's largest union, met with over 40 other European union representatives from 9 countries in Brussels in advance of an expected re-structuring announcement by the IT company Hewlett Packard (HP) next week.

The HP announcement, due on Monday 15th September, follows its takeover of EDS, and is predicted by the unions to contain details of substantial job cuts in the UK and worldwide.

The unions are concerned about the impact on employment and working conditions of the EDS takeover by HP, and are also dissatisfied about the lack of information provided by HP and EDS to date.

MUMBAI, India, September 12 /PRNewswire/ -- Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE:SUNPHARMA, BSE: 524715) announced that USFDA has granted final approval for the Company's Abbreviated New Drug Application (ANDA) for generic Fosamax (R), alendronate sodium tablets.

Alendronate sodium tablets are indicated for the treatment and prevention of osteoporosis in post menopausal women, to increase bone mass in men with osteoporosis, in the treatment of glucocorticoid induced osteoporosis, and Paget's disease of the bone in men and women.

These generic versions of alendronate sodium tablets 5 mg (base), 10 mg (base), 35 mg (base) and 70 mg (base) are bio-equivalent to Fosamax (R) tablets distributed by Merck & Co.

COPENHAGEN, September 12 /PRNewswire/ --

WHEN: Monday to Thursday, 15-18 September 2008

WHERE: Tbilisi, Georgia; Sheraton Metechi Palace Hotel, 20 Telavi St.

WHAT: The WHO European governing body meets in Georgia next week for its annual session. Health officials from the 53 Member States of the WHO European Region will discuss the progress they have made on issues such as governance of health systems, health promotion, chronic diseases, child and adolescent health and the social determinants of health.

A key part of this will be a review of the work done by the WHO Regional Office for Europe during the 2006-2007, to act on its commitment to helping its Member States to reform their health sectors.

BASEL, Switzerland, September 12 /PRNewswire/ --

- Avastin Shows Unprecedented Patient Benefits Regardless of K-Ras Status, Age and Chemotherapy Choice

Avastin's (bevacizumab) essential role in the treatment of patients with metastatic colorectal cancer (mCRC), the world's second most common cancer, was strengthened at the 33rd European Society of Medical Oncology (ESMO) meeting with a compelling data set including:

- the final overall survival analysis of a 2,000 patient community-based study - further analyses of the Avastin and cetuximab combination study highlighting K-Ras findings - strong and consistent outcome for elderly patients on Avastin-based therapy

Long-term overall survival reported from First BEAT (1)

AMSTERDAM, Netherlands, September 12 /PRNewswire/ --

- Demonstrations Illustrate Advanced Functionality Beyond Mobile TV and Highlight the Immersive, Personalized Nature of Interactive Mobile Broadcast Services -